ITT Other Non-Current Liabilities increased by 250.8% to $979.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 266.9%, from $267.10M to $979.90M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 5.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $200.00M | $194.90M | $206.50M | $196.70M | $189.00M | $185.40M | $200.20M | $199.60M | $216.20M | $207.10M | $211.30M | $254.10M | $252.40M | $311.30M | $260.70M | $267.10M | $282.20M | $281.50M | $279.30M | $979.90M |
| QoQ Change | — | -2.5% | +6.0% | -4.7% | -3.9% | -1.9% | +8.0% | -0.3% | +8.3% | -4.2% | +2.0% | +20.3% | -0.7% | +23.3% | -16.3% | +2.5% | +5.7% | -0.2% | -0.8% | +250.8% |
| YoY Change | — | — | — | — | -5.5% | -4.9% | -3.1% | +1.5% | +14.4% | +11.7% | +5.5% | +27.3% | +16.7% | +50.3% | +23.4% | +5.1% | +11.8% | -9.6% | +7.1% | +266.9% |